FRONTLINE COMBO SPOT-ON DOG L
Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Summary of Product characteristics
(SPC)
28-01-2015
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
FIPRONIL, METHOPRENE
Available from:
Merial Animal Health Limited
ATC code:
QP53AX65
INN (International Name):
FIPRONIL, METHOPRENE
Dosage:
Unknown
Pharmaceutical form:
Spot On Solution
Prescription type:
POM
Therapeutic group:
Canine
Therapeutic area:
Fipronil, combinations
Therapeutic indications:
Ectoparasiticide
Authorization status:
Authorised
Authorization date:
2004-05-14
Summary of Product characteristics
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Frontline Combo Spot-on Dog L.
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each pipette of 2.68 ml contains:
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Spot-on solution.
Clear amber solution.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Dogs.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the treatment of dogs weighing 20-to-40 kg bodyweight:
-
To be used against infestations with fleas, alone or in association with ticks and/or biting lice.
-
Treatment of flea infestations (_Ctenocephalides _spp.). Insecticidal efficacy against new infestations with adult fleas
persists for 8 weeks. Prevention of the multiplication of fleas by inhibiting the development of eggs (ovicidal activity)
and larvae and pupae (larvicidal activity) originating from eggs laid by adult fleas for eight weeks after application.
-
Treatment of tick infestations (_Ixodes ricinus_, _Dermacentor variabilis_, _Dermacentor reticulatus_, _Rhipicephalus_
_sanguineus_). The product has a persistent acaricidal efficacy for up to 4 weeks against ticks.
-
Treatment of infestations with biting lice (_Trichodectes canis_).
The product can be used as part of a treatment strategy for the control of Flea Allergy Dermatitis (FAD).
4.3 CONTRAINDICATIONS
In the absence of available data, the product should not be used on puppies less than 8 weeks old.
DO NOT USE IN RABBITS, AS ADVERSE REACTIONS WITH EVEN MORTALITY COULD OCCUR. In absence of studies, the use of the
product is not recommended in non-target species.
Do not use on sick (e.g. systemic diseases, fever) or convalescent animals.
This product is specifically developed for dogs. Do not use in cats and ferrets, as this could lead to overdosing.
Fipronil
Read the complete document
